AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] Intel Corp Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Intel Corporation filed a prospectus supplement on September 5, 2025 to register the potential resale by the United States Department of Commerce of a warrant and 673,839,150 shares of common stock. The Warrant permits purchase of up to 240,516,150 shares at an initial exercise price of $20.00 per share. The 673,839,150 shares consist of 274,583,000 shares issued to the selling securityholder, 158,740,000 shares held in escrow subject to conditions in the Purchase Agreement, and 240,516,150 shares issuable upon exercise of the Warrant. The prospectus supplement was filed under Intel’s existing Form S-3ASR shelf registration. The filing itself is not a sale, would not generate proceeds for Intel if the selling securityholder sells, and no securities are being issued or sold by Intel under the supplement. A legal opinion as to the validity of the shares and the Warrant is attached as Exhibit 5.1 and is incorporated by reference.

Intel Corporation ha depositato un supplemento al prospetto il 5 settembre 2025 per registrare la possibile rivendita, da parte del Dipartimento del Commercio degli Stati Uniti, di un warrant e di 673.839.150 azioni ordinarie. Il warrant consente l’acquisto fino a 240.516.150 azioni a un prezzo di esercizio iniziale di $20,00 per azione. Le 673.839.150 azioni sono composte da 274.583.000 azioni emesse al soggetto venditore, 158.740.000 azioni vincolate in escrow soggette alle condizioni previste dall’Accordo d’Acquisto e 240.516.150 azioni emettibili in seguito all’esercizio del warrant. Il supplemento è stato presentato nell’ambito del shelf registration Form S-3ASR già in essere di Intel. Il deposito non costituisce una vendita, non genererebbe proventi per Intel qualora il soggetto venditore cedesse le azioni, e Intel non sta emettendo né vendendo titoli con questo supplemento. Un parere legale sulla validità delle azioni e del warrant è allegato come Exhibit 5.1 e qui incorporato per riferimento.

Intel Corporation presentó un suplemento al prospecto el 5 de septiembre de 2025 para registrar la posible reventa por parte del Departamento de Comercio de los Estados Unidos de un warrant y 673.839.150 acciones ordinarias. El warrant permite la compra de hasta 240.516.150 acciones a un precio de ejercicio inicial de $20,00 por acción. Las 673.839.150 acciones comprenden 274.583.000 acciones emitidas al titular vendedor, 158.740.000 acciones en custodia (escrow) sujetas a las condiciones del Acuerdo de Compra y 240.516.150 acciones susceptibles de emitirse al ejercer el warrant. El suplemento se presentó bajo el registro en shelf Form S-3ASR vigente de Intel. La presentación en sí no constituye una venta, no generaría ingresos para Intel si el titular vendedor vende, y Intel no está emitiendo ni vendiendo valores en virtud del suplemento. Un dictamen legal sobre la validez de las acciones y del warrant se adjunta como Exhibit 5.1 e incorpora por referencia.

Intel Corporationì€ 2025ë…� 9ì›� 5ì¼ìžë¡� ì¦ê¶Œ ë§¤ê° ê°€ëŠ¥ì„±ì� 등ë¡í•˜ê¸° 위한 ì¦ê¶Œì„¤ëª…ì„� 보충서를 제출했습니다. ì´ëŠ” 미국 ìƒë¬´ë¶€ê°€ 워런íŠ�ê³� 673,839,150ì£�ì� 보통주를 잠재ì ìœ¼ë¡� 재매ê°í•˜ëŠ� 것과 관련ë©ë‹ˆë‹¤. 해당 워런트는 초기 행사가ê²� 주당 $20.00ë¡� 최대 240,516,150ì£�ë¥� 매수í•� ìˆ� 있ë„ë¡� 허용합니ë‹�. 673,839,150주는 íŒë§¤ì¦ê¶Œë³´ìœ ìžì—ê²� 발행ë� 274,583,000ì£�, 매매계약ì� ì¡°ê±´ì—� ë”°ë¼ ì—스í¬ë¡œì—� ë³´ê´€ë� 158,740,000ì£�, 그리ê³� 워런íŠ� 행사ë¡� 발행ë� ìˆ� 있는 240,516,150주로 구성ë©ë‹ˆë‹�. ì� 보충서는 Intelì� 기존 Form S-3ASR 선반등ë¡(shelf registration) í•˜ì— ì œì¶œë˜ì—ˆìŠµë‹ˆë‹�. ì� 제출 ìžì²´ëŠ� 매ê°ì� ì˜ë¯¸í•˜ì§€ 않으ë©�, íŒë§¤ì¦ê¶Œë³´ìœ ìžê°€ 매ê°í•� 경우 Intelì—게 수ìµì� ë°œìƒì‹œí‚¤ì§€ 않고, ì� ë³´ì¶©ì„œì— ë”°ë¼ Intelì� ì¦ê¶Œì� 발행하거ë‚� íŒë§¤í•˜ëŠ” ê²ƒë„ ì•„ë‹™ë‹ˆë‹¤. 주ì‹ê³� ì›ŒëŸ°íŠ¸ì˜ ìœ íš¨ì„±ì— ê´€í•� 법률 ì˜ê²¬ì„œëŠ” Exhibit 5.1ë¡� 첨부ë˜ì–´ 참조ì—� í¬í•¨ë©ë‹ˆë‹�.

Intel Corporation a déposé un supplément de prospectus le 5 septembre 2025 afin d’enregistrer la revente potentielle par le département du Commerce des États-Unis d’un warrant et de 673 839 150 actions ordinaires. Le warrant permet l’achat d’au plus 240 516 150 actions à un prix d’exercice initial de 20,00 $ par action. Les 673 839 150 actions se composent de 274 583 000 actions émises au titulaire vendeur, de 158 740 000 actions détenues en séquestre (escrow) soumises aux conditions de l’accord d’achat, et de 240 516 150 actions susceptibles d’être émises à l’exercice du warrant. Le supplément de prospectus a été déposé au titre de l’enregistrement en shelf existant d’Intel, Form S-3ASR. Le dépôt en lui‑même ne constitue pas une vente, ne générerait pas de produits pour Intel si le titulaire vendeur vendait, et aucune valeur mobilière n’est émise ni vendue par Intel en vertu du supplément. Un avis juridique sur la validité des actions et du warrant est joint en tant qu’Exhibit 5.1 et incorporé par référence.

Intel Corporation reichte am 5. September 2025 ein Prospektergänzungsblatt ein, um den möglichen Weiterverkauf durch das US-Handelsministerium eines Warrants und von 673.839.150 Stammaktien zu registrieren. Der Warrant berechtigt zum Kauf von bis zu 240.516.150 Aktien zu einem anfänglichen Ausübungspreis von $20,00 je Aktie. Die 673.839.150 Aktien setzen sich zusammen aus 274.583.000 an den verkaufenden Wertpapierinhaber ausgegebenen Aktien, 158.740.000 Aktien, die treuhänderisch (Escrow) gehalten und an die Bedingungen des Kaufvertrags gebunden sind, sowie 240.516.150 Aktien, die durch Ausübung des Warrants ausgegeben werden können. Das Ergänzungsblatt wurde im Rahmen des bestehenden Form S-3ASR Shelf-Registerings von Intel eingereicht. Die Einreichung selbst stellt keinen Verkauf dar, würde Intel keine Einnahmen verschaffen, falls der veräußernde Inhaber verkauft, und Intel gibt beziehungsweise verkauft im Rahmen des Ergänzungsblatts keine Wertpapiere. Ein Rechtsgutachten zur Gültigkeit der Aktien und des Warrants ist als Exhibit 5.1 beigefügt und durch Verweis aufgenommen.

Positive
  • Prospectus supplement filed to register potential resale, providing transparency on the securityholder's ability to resell
  • Legal opinion (Exhibit 5.1) attached, addressing validity of the shares and the Warrant
  • Filing was made under Intel's existing Form S-3ASR shelf registration, indicating reliance on previously filed registration
Negative
  • The prospectus supplement does not itself constitute a sale and Intel would receive no proceeds if the selling securityholder sells any registered securities

Insights

TL;DR: Intel registered a large resale block and a substantial warrant, clarifying that the filing is procedural and not a sale.

The company filed a prospectus supplement to register resale by the Department of Commerce of a warrant and 673,839,150 shares of common stock, detailing exact share counts and the Warrant exercise price of $20.00. The filing relies on an existing Form S-3ASR shelf registration and incorporates the Purchase Agreement and Form of Warrant by reference. The company explicitly states the prospectus supplement does not constitute a sale and that Intel would receive no proceeds if the selling securityholder sells.

TL;DR: The filing documents transfer mechanics and legal support but does not alter Intel’s capital structure absent any resale or exercise.

Intel provided the legal opinion (Exhibit 5.1) validating the registered shares and Warrant and referenced the Purchase Agreement exhibits previously filed. The supplement clarifies the composition of the registered shares—issued, escrowed, and issuable upon Warrant exercise—and reiterates that no new securities are being issued by Intel through the resale filing itself.

Intel Corporation ha depositato un supplemento al prospetto il 5 settembre 2025 per registrare la possibile rivendita, da parte del Dipartimento del Commercio degli Stati Uniti, di un warrant e di 673.839.150 azioni ordinarie. Il warrant consente l’acquisto fino a 240.516.150 azioni a un prezzo di esercizio iniziale di $20,00 per azione. Le 673.839.150 azioni sono composte da 274.583.000 azioni emesse al soggetto venditore, 158.740.000 azioni vincolate in escrow soggette alle condizioni previste dall’Accordo d’Acquisto e 240.516.150 azioni emettibili in seguito all’esercizio del warrant. Il supplemento è stato presentato nell’ambito del shelf registration Form S-3ASR già in essere di Intel. Il deposito non costituisce una vendita, non genererebbe proventi per Intel qualora il soggetto venditore cedesse le azioni, e Intel non sta emettendo né vendendo titoli con questo supplemento. Un parere legale sulla validità delle azioni e del warrant è allegato come Exhibit 5.1 e qui incorporato per riferimento.

Intel Corporation presentó un suplemento al prospecto el 5 de septiembre de 2025 para registrar la posible reventa por parte del Departamento de Comercio de los Estados Unidos de un warrant y 673.839.150 acciones ordinarias. El warrant permite la compra de hasta 240.516.150 acciones a un precio de ejercicio inicial de $20,00 por acción. Las 673.839.150 acciones comprenden 274.583.000 acciones emitidas al titular vendedor, 158.740.000 acciones en custodia (escrow) sujetas a las condiciones del Acuerdo de Compra y 240.516.150 acciones susceptibles de emitirse al ejercer el warrant. El suplemento se presentó bajo el registro en shelf Form S-3ASR vigente de Intel. La presentación en sí no constituye una venta, no generaría ingresos para Intel si el titular vendedor vende, y Intel no está emitiendo ni vendiendo valores en virtud del suplemento. Un dictamen legal sobre la validez de las acciones y del warrant se adjunta como Exhibit 5.1 e incorpora por referencia.

Intel Corporationì€ 2025ë…� 9ì›� 5ì¼ìžë¡� ì¦ê¶Œ ë§¤ê° ê°€ëŠ¥ì„±ì� 등ë¡í•˜ê¸° 위한 ì¦ê¶Œì„¤ëª…ì„� 보충서를 제출했습니다. ì´ëŠ” 미국 ìƒë¬´ë¶€ê°€ 워런íŠ�ê³� 673,839,150ì£�ì� 보통주를 잠재ì ìœ¼ë¡� 재매ê°í•˜ëŠ� 것과 관련ë©ë‹ˆë‹¤. 해당 워런트는 초기 행사가ê²� 주당 $20.00ë¡� 최대 240,516,150ì£�ë¥� 매수í•� ìˆ� 있ë„ë¡� 허용합니ë‹�. 673,839,150주는 íŒë§¤ì¦ê¶Œë³´ìœ ìžì—ê²� 발행ë� 274,583,000ì£�, 매매계약ì� ì¡°ê±´ì—� ë”°ë¼ ì—스í¬ë¡œì—� ë³´ê´€ë� 158,740,000ì£�, 그리ê³� 워런íŠ� 행사ë¡� 발행ë� ìˆ� 있는 240,516,150주로 구성ë©ë‹ˆë‹�. ì� 보충서는 Intelì� 기존 Form S-3ASR 선반등ë¡(shelf registration) í•˜ì— ì œì¶œë˜ì—ˆìŠµë‹ˆë‹�. ì� 제출 ìžì²´ëŠ� 매ê°ì� ì˜ë¯¸í•˜ì§€ 않으ë©�, íŒë§¤ì¦ê¶Œë³´ìœ ìžê°€ 매ê°í•� 경우 Intelì—게 수ìµì� ë°œìƒì‹œí‚¤ì§€ 않고, ì� ë³´ì¶©ì„œì— ë”°ë¼ Intelì� ì¦ê¶Œì� 발행하거ë‚� íŒë§¤í•˜ëŠ” ê²ƒë„ ì•„ë‹™ë‹ˆë‹¤. 주ì‹ê³� ì›ŒëŸ°íŠ¸ì˜ ìœ íš¨ì„±ì— ê´€í•� 법률 ì˜ê²¬ì„œëŠ” Exhibit 5.1ë¡� 첨부ë˜ì–´ 참조ì—� í¬í•¨ë©ë‹ˆë‹�.

Intel Corporation a déposé un supplément de prospectus le 5 septembre 2025 afin d’enregistrer la revente potentielle par le département du Commerce des États-Unis d’un warrant et de 673 839 150 actions ordinaires. Le warrant permet l’achat d’au plus 240 516 150 actions à un prix d’exercice initial de 20,00 $ par action. Les 673 839 150 actions se composent de 274 583 000 actions émises au titulaire vendeur, de 158 740 000 actions détenues en séquestre (escrow) soumises aux conditions de l’accord d’achat, et de 240 516 150 actions susceptibles d’être émises à l’exercice du warrant. Le supplément de prospectus a été déposé au titre de l’enregistrement en shelf existant d’Intel, Form S-3ASR. Le dépôt en lui‑même ne constitue pas une vente, ne générerait pas de produits pour Intel si le titulaire vendeur vendait, et aucune valeur mobilière n’est émise ni vendue par Intel en vertu du supplément. Un avis juridique sur la validité des actions et du warrant est joint en tant qu’Exhibit 5.1 et incorporé par référence.

Intel Corporation reichte am 5. September 2025 ein Prospektergänzungsblatt ein, um den möglichen Weiterverkauf durch das US-Handelsministerium eines Warrants und von 673.839.150 Stammaktien zu registrieren. Der Warrant berechtigt zum Kauf von bis zu 240.516.150 Aktien zu einem anfänglichen Ausübungspreis von $20,00 je Aktie. Die 673.839.150 Aktien setzen sich zusammen aus 274.583.000 an den verkaufenden Wertpapierinhaber ausgegebenen Aktien, 158.740.000 Aktien, die treuhänderisch (Escrow) gehalten und an die Bedingungen des Kaufvertrags gebunden sind, sowie 240.516.150 Aktien, die durch Ausübung des Warrants ausgegeben werden können. Das Ergänzungsblatt wurde im Rahmen des bestehenden Form S-3ASR Shelf-Registerings von Intel eingereicht. Die Einreichung selbst stellt keinen Verkauf dar, würde Intel keine Einnahmen verschaffen, falls der veräußernde Inhaber verkauft, und Intel gibt beziehungsweise verkauft im Rahmen des Ergänzungsblatts keine Wertpapiere. Ein Rechtsgutachten zur Gültigkeit der Aktien und des Warrants ist als Exhibit 5.1 beigefügt und durch Verweis aufgenommen.

0000050863falsefalse00000508632025-09-052025-09-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 5, 2025
intellogo.jpg
INTEL CORPORATION
(Exact name of registrant as specified in its charter)
Delaware000-0621794-1672743
(State or other jurisdiction(Commission(IRS Employer
of incorporation)File Number)Identification No.)
 
2200 Mission College Boulevard, Santa Clara, California
95054-1549
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (408) 765-8080

Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.001 par valueINTCNasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨



Item 8.01    Other Events.
On September 5, 2025, as required by the Warrant and Common Stock Agreement, dated as of August 22, 2025 (the “Purchase Agreement”), by and between Intel Corporation (the “Company”) and the United States Department of Commerce (the “selling securityholder”), the Company filed a prospectus supplement with the Securities and Exchange Commission (the “SEC”) solely to register the potential resale by the selling securityholder of (i) a warrant to purchase up to 240,516,150 shares of the Company’s common stock, par value $0.001 per share (the “common stock”) at an initial exercise price of $20.00 per share (the “Warrant”) and (ii) 673,839,150 shares of common stock. The shares of common stock represent (x) 274,583,000 shares issued to the selling securityholder pursuant to the Purchase Agreement, (y) 158,740,000 shares issued into escrow for the benefit of the selling securityholder subject to the satisfaction of certain escrow conditions set forth in the Purchase Agreement and (z) 240,516,150 shares issuable to the selling securityholder should it choose to exercise the Warrant. This description is not complete and is subject to, and qualified in its entirety by reference to the full text of, the Form of Warrant and the Purchase Agreement attached as Exhibits 4.1 and 10.1, respectively, to our Current Report on Form 8-K filed with the SEC on August 25, 2025, and incorporated herein by reference.
The filing of the resale prospectus supplement is not itself a sale of securities by the selling securityholder and does not necessarily mean that the selling securityholder will choose to sell any shares of common stock or the Warrant. If any shares of common stock or the Warrant are sold by the selling securityholder, the Company would not receive any proceeds from that sale. No securities will be issued or sold by the Company pursuant to the resale prospectus supplement.
The resale prospectus supplement was filed pursuant to the Company’s automatic “shelf” Registration Statement on Form S-3ASR (File No. 333-269522), previously filed with the SEC on February 2, 2023. The Company is filing this current report to provide the legal opinion as to the validity of the shares of common stock and the Warrant covered by the resale prospectus supplement, which opinion is attached hereto as Exhibit 5.1 and is incorporated herein by reference.
Item 9.01     Financial Statements and Exhibits.
(d)     Exhibits.
The following exhibits are provided as part of this report:
Exhibit NumberDescription
5.1
Opinion of Skadden, Arps, Slate, Meagher & Flom LLP
23.1Consent of Skadden, Arps, Slate, Meagher & Flom LLP (included in Exhibit 5.1)
104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INTEL CORPORATION
(Registrant)
Date:September 5, 2025By:/s/ April Miller Boise
April Miller Boise
Executive Vice President and Chief Legal Officer

FAQ

What did Intel (INTC) register in the prospectus supplement filed September 5, 2025?

Intel registered the potential resale by the U.S. Department of Commerce of a warrant to purchase up to 240,516,150 shares at an initial exercise price of $20.00 and 673,839,150 shares of common stock.

How are the 673,839,150 registered shares composed?

They consist of 274,583,000 shares issued to the selling securityholder, 158,740,000 shares in escrow subject to escrow conditions, and 240,516,150 shares issuable upon exercise of the Warrant.

Does the prospectus supplement mean Intel is selling new shares?

No. The filing expressly states that the prospectus supplement is not a sale, no securities are being issued or sold by Intel under the supplement, and Intel would not receive proceeds if the selling securityholder sells shares or the Warrant.

Under what registration was the prospectus supplement filed?

The supplement was filed pursuant to Intel’s automatic shelf Registration Statement on Form S-3ASR (File No. 333-269522), previously filed on February 2, 2023.

What supporting documents are referenced or attached to the filing?

The filing references the Form of Warrant and the Purchase Agreement (previously filed as Exhibits 4.1 and 10.1) and attaches a legal opinion as Exhibit 5.1 regarding validity of the shares and the Warrant.
Intel Corp

NASDAQ:INTC

INTC Rankings

INTC Latest News

INTC Latest SEC Filings

INTC Stock Data

107.72B
4.37B
0.08%
69.63%
2.75%
Semiconductors
Semiconductors & Related Devices
United States
SANTA CLARA